Literature DB >> 20643298

The evolutionary role of nutrition and metabolic support in critical illness.

Nicolas Mongardon1, Mervyn Singer.   

Abstract

Maintenance of nutritional status is particularly challenging during critical illness. There is a common perception of a race against the clock to adequately feed the patient to prevent or minimize the sometimes catastrophic muscle wasting and general catabolic state that can result in the patient's deterioration. However, the course of critical illness may be separated into 3 phases, each with highly differing metabolic needs. The initial phase, in which the body attempts to fight the acute insult, is generally hypermetabolic. When the body fails to overcome the insult, it enters into a second phase, which is akin to hibernation. This stage is characterized by a functional metabolic shutdown triggered either by a lack of adequate energy supply or perhaps by the direct switching off of metabolism to spare excess use of a dwindling substrate and energy resource. Those strong enough to survive this phase enter into a period of recovery during which appetite returns, anabolism recommences, and organ function is restored. Nutrition should perhaps closely follow these nonlinear requirements, so as to avoid deleterious under- or overnutrition during the appropriate phase. This approach fits a teleologic argument that enabled many sick people to survive well before the advent of modern medicine and explains why catabolism still occurs despite adequate feeding. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20643298     DOI: 10.1016/j.ccc.2010.04.001

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  7 in total

Review 1.  Anabolic and anticatabolic agents in critical care.

Authors:  Mile Stanojcic; Celeste C Finnerty; Marc G Jeschke
Journal:  Curr Opin Crit Care       Date:  2016-08       Impact factor: 3.687

2.  Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days.

Authors:  Till Hauffe; Bernard Krüger; Dominique Bettex; Alain Rudiger
Journal:  Card Fail Rev       Date:  2016-05

Review 3.  Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?

Authors:  Gerd G Gauglitz; Felicia N Williams; David N Herndon; Marc G Jeschke
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

4.  Enteral nutrition is associated with improved outcome in patients with severe sepsis. A secondary analysis of the VISEP trial.

Authors:  G Elke; E Kuhnt; M Ragaller; D Schädler; I Frerichs; F M Brunkhorst; M Löffler; K Reinhart; N Weiler
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-03       Impact factor: 0.840

5.  Prolonged triglyceride storage in macrophages: pHo trumps pO2 and TLR4.

Authors:  Mingfang Lu; Terry Kho; Robert S Munford
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

6.  Energy expenditure and feeding practices and tolerance during the acute and late phase of critically ill COVID-19 patients.

Authors:  P L M Lakenman; B van der Hoven; J M Schuijs; R D Eveleens; J van Bommel; J F Olieman; K F M Joosten
Journal:  Clin Nutr ESPEN       Date:  2021-04-02

7.  Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach.

Authors:  Marie-Angélique Cazalis; Alain Lepape; Fabienne Venet; Florence Frager; Bruno Mougin; Hélène Vallin; Malick Paye; Alexandre Pachot; Guillaume Monneret
Journal:  Intensive Care Med Exp       Date:  2014-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.